Skip to main content

search

News
About Us
What is Vitiligo?
Partnership
VIPOC Conference
Contact Us

Join Now
search

WCD 2023

Home » WCD 2023

WCD_VIPOC_2023_1

WCD_VIPOC_2023_1

WCD_VIPOC_2023_2

WCD_VIPOC_2023_2

WCD_VIPOC_2023_3

WCD_VIPOC_2023_3

WCD_VIPOC_2023_4

WCD_VIPOC_2023_4

WCD_VIPOC_2023_5

WCD_VIPOC_2023_5

WCD_VIPOC_2023_5

WCD_VIPOC_2023_5

WCD_VIPOC_2023_6

WCD_VIPOC_2023_6

WCD_VIPOC_2023_7

WCD_VIPOC_2023_7

WCD_VIPOC_2023_8

WCD_VIPOC_2023_8

WCD_VIPOC_2023_9

WCD_VIPOC_2023_9

Share Tweet Share

About VIPOC

Vipoc created an international alliance of vitiligo patient organizations and is dedicated to raise awareness and support research for this condition.

Quick Links

About Us
What is Vitiligo
Partnership
News
Contact Us

Translate

Recent News

Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo 21 October 2024
EADV Amsterdam 25-28 September 2024 7 October 2024
Opzelura the first drug against vitiligo available in pharmacies 4 October 2024

© 2024 VIPOC. Copyright © VIPOC Built by Simboti Digital All rights reserved.|Privacy Policy - English|Privacy Policy - French

facebook
linkedin
instagram

News
About Us
What is Vitiligo?
Partnership
VIPOC Conference
Contact Us
Join Now

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok